Catalyst Wire Dossier Catalyst Wire Dossier

Antigen-specific Engineered Immune Effectors

· Shenzhen Geno-Immune Medical Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Antigen-specific Engineered Immune Effectors, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors [Phase 1, Phase 2]

See pricing